TERT and colorectal cancer: Inversely, the TERT rs2736100 polymorphism was associated with decreased colorectal cancer risk (homozygous model: OR=0.86, 95% CI=0.82–0.91, P=0.512; dominant model: OR=0.94, 95% CI=0.90–0.98, P=0.970; recessive model: OR=0.88, 95% CI=0.82–0.96, P=0.279; and allele contrast model: OR=0.93, 95% CI=0.90–0.96, P=0.548).